PI Industries Limited has filed a regulatory disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the unveiling of Pioxaniliprole, India's first indigenously discovered insecticide molecule.

Key Development Details

Pioxaniliprole is India's first indigenously discovered insecticide molecule developed through more than a decade of original research, sustained investment, and scientific innovation. The molecule was developed to global scientific standards and has undergone extensive evaluation under Indian agricultural conditions, including multilocation field trials, scientific assessments, and regulatory studies.

Regulatory Approval

The molecule has received registration from the Central Insecticides Board and Registration Committee (CIB&RC) under the Ministry of Agriculture & Farmers Welfare, Government of India. The Committee formally recognized it as the first insecticide active ingredient discovered in India.

Research and Development Capabilities

The discovery reflects PI's long-term investment in an integrated R&D ecosystem spanning molecular discovery, chemistry, biology, formulation science, toxicology, agronomy, process development, and manufacturing. The company has over 700 scientists, more than 200 PhDs, and a portfolio of over 260 patents.

Management Commentary

Mayank Singhal, Vice Chairperson & Managing Director stated that this achievement required courage to challenge conventional wisdom, substantial long-term investment, and conviction to pursue what had never been achieved before. He emphasized that this strengthens the company's ambition to build a global, innovation-led Life Sciences company.

Narayan K. Seshadri, Chairperson noted that Pioxaniliprole represents an important milestone in the evolution of Indian agricultural science and reinforces the company's commitment to building a sustained innovation pipeline.

Strategic Significance

The achievement marks India's growing capability to originate novel scientific discoveries and create proprietary intellectual property. It is the first outcome of a broader innovation pipeline at PI spanning chemistry, biology, and biochemical solutions, representing an important step in India's journey toward greater scientific self-reliance.

Additional Information

The press release is available on the company's website at https://www.piindustries.com/investor/disclosure/press-release-other/

Disclosure Authority

The intimation was signed by Shruti Joshi, Company Secretary and Compliance Officer, and was digitally signed on October 29, 2026.